Copenhagen, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Gene therapy's biggest obstacle isn't science - it's manufacturing. While the field races forward with breakthrough treatments, production remains stuck ...
As more cell, gene and immunotherapy applications emerge for lentiviral vectors, demand for their production continues to rise. With its move last week into a larger manufacturing facility, CDMO ...
HIV particles produced by cells superinfected with other viruses, such as Moloney murine leukaemia virus, herpes simplex virus and vesicular stomatitis virus (VSV), display an expanded cell tropism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback